Core Operating Profit (excluding trading gain) grew by 15% YOY from Rs. 1,515 crore in Q3 FY24 to Rs. 1,736 crore for Q3 FY25, impacted by micro-finance business. Including trading gains, operating ...
Cingulate Inc. (NASDAQ:CING), a micro-cap pharmaceutical company with a market value of $16.4 million specializing in the development of central nervous system (CNS) therapeutics, has announced ...